{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:05:15Z","timestamp":1776405915562,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.lfs.2023.121465","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T22:14:38Z","timestamp":1675116878000},"page":"121465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The effect of mesenchymal stem cell-derived supernatant nasal administration on lung inflammation and immune response in BCG-vaccinated BALB\/c mice"],"prefix":"10.1016","volume":"317","author":[{"given":"Abolfazl","family":"Chenari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hazrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Zavaran","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdieh","family":"Motiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Soudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121465_bb0005","first-page":"1","article-title":"The potential use of mesenchymal stem cells and their derived exosomes for orthopedic diseases treatment","author":"Malekpour","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2023.121465_bb0010","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61167-z","article-title":"A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential","volume":"10","author":"Petrenko","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.121465_bb0020","first-page":"273","article-title":"Wharton's jelly mesenchymal stem cells-derived exosomes and imipenem in combination reduce apoptosis and inflammatory responses in E. Coli-infected HepG2 cells","volume":"21","author":"Hazrati","year":"2022","journal-title":"Iran. J. Allergy Asth. Immunol."},{"key":"10.1016\/j.lfs.2023.121465_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcell.2020.00149","article-title":"Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications","volume":"8","author":"Gowen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2023.121465_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113211","article-title":"Mesenchymal stromal\/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: a new strategy to overcome cell therapy limitations","volume":"152","author":"Hazrati","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.lfs.2023.121465_bb0035","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","article-title":"Interactions between mesenchymal stem cells and the immune system","volume":"74","author":"Li","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.121465_bb0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000143110","article-title":"Homing of mesenchymal stem cells","volume":"35","author":"Henschler","year":"2008","journal-title":"Transfus. Med. Hemother."},{"issue":"2","key":"10.1016\/j.lfs.2023.121465_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.gt.3303067","article-title":"Human mesenchymal stem cells: from basic biology to clinical applications","volume":"15","author":"Abdallah","year":"2008","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-03050-4","article-title":"The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment","volume":"13","author":"Heris","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.lfs.2023.121465_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4252\/wjsc.v6.i3.344","article-title":"Mesenchymal stem cells as a potent cell source for articular cartilage regeneration","volume":"6","author":"Eslaminejad","year":"2014","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.lfs.2023.121465_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113943","article-title":"CRISPR\/Cas9-engineered mesenchymal stromal\/stem cells and their extracellular vesicles: a new approach to overcoming cell therapy limitations","volume":"156","author":"Hazrati","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0065","first-page":"1","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct.. Target. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-03125-5","article-title":"Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration","volume":"19","author":"Lin","year":"2021","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121465_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.scr.2011.01.001","article-title":"Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction","volume":"6","author":"Timmers","year":"2011","journal-title":"Stem Cell Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121465_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096161","article-title":"Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121465_bb0085","doi-asserted-by":"crossref","DOI":"10.1159\/000524484","article-title":"Conditioned medium from human uterine cervical stem cells regulates oxidative stress and angiogenesis of retinal pigment epithelial cells","author":"Eiro","year":"2022","journal-title":"Ophthalmic Res."},{"issue":"11","key":"10.1016\/j.lfs.2023.121465_bb0090","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/jcp.26765","article-title":"The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis","volume":"233","author":"Heidari","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121465_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12015-016-9677-1","article-title":"Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem\/stroma cells in a mice model of colitis","volume":"12","author":"Legaki","year":"2016","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01895-1","article-title":"Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury","volume":"11","author":"Hu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.lfs.2023.121465_bb0105","first-page":"13","article-title":"Mesenchymal stromal\/stem cells and their extracellular vesicles application in acute and chronic inflammatory liver diseases: emphasizing on the anti-fibrotic and immunomodulatory mechanisms","author":"Hazrati","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121465_bb0110","first-page":"217","article-title":"Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli","volume":"68","author":"Burja","year":"2020","journal-title":"Curr. Res. Transl. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.121465_bb0115","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1128\/AAC.00028-08","article-title":"The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)\/CXCL6 possesses membrane-disrupting properties and is antibacterial","volume":"52","author":"Linge","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.lfs.2023.121465_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.imlet.2015.05.020","article-title":"Mesenchymal stem cells and infectious diseases: smarter than drugs","volume":"168","author":"Mezey","year":"2015","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2023.121465_bb0125","first-page":"149","article-title":"Tuberculosis: a global overview of the situation today","volume":"70","author":"Sudre","year":"1992","journal-title":"Bull. World Health Organ."},{"issue":"12","key":"10.1016\/j.lfs.2023.121465_bb0130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.15585\/mmwr.mm7012a1","article-title":"Tuberculosis\u2014United States, 2020","volume":"70","author":"Deutsch-Feldman","year":"2021","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-pathol-011811-132458","article-title":"Tuberculosis pathogenesis and immunity","volume":"7","author":"Philips","year":"2012","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.lfs.2023.121465_bb0140","series-title":"Seminars in Immunology","article-title":"Pro-and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis","author":"Etna","year":"2014"},{"key":"10.1016\/j.lfs.2023.121465_bb0145","series-title":"Seminars in Immunology","article-title":"The formation of the granuloma in tuberculosis infection","author":"Orme","year":"2014"},{"issue":"7","key":"10.1016\/j.lfs.2023.121465_bb0150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/jis778","article-title":"Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis","volume":"207","author":"Mehra","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jmii.2014.11.019","article-title":"Recombinant bacille calmette-guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis","volume":"50","author":"Chen","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.lfs.2023.121465_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2015.01.016","article-title":"Cellular therapy in tuberculosis","volume":"32","author":"Parida","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2023.121465_bb0165","series-title":"Clinical Trials in Critical Care","first-page":"A6043","article-title":"Safety of cell therapy with mesenchymal stromal cells (MSCs): a systematic review. D49","author":"Lalu","year":"2010"},{"key":"10.1016\/j.lfs.2023.121465_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jctube.2016.05.003","article-title":"Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis","volume":"4","author":"Skrahin","year":"2016","journal-title":"J. Clin. Tuberculosis Other Mycobacter. Dis."},{"key":"10.1016\/j.lfs.2023.121465_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tube.2016.09.005","article-title":"BCG infection in mice is promoted by naive mesenchymal stromal cells (MSC) and suppressed by poly (A: U)-conditioned MSC","volume":"101","author":"Schwartz","year":"2016","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.lfs.2023.121465_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178983","article-title":"The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. Tuberculosis infected mice","volume":"12","author":"Nenasheva","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.121465_bb0185","first-page":"1","article-title":"Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.lfs.2023.121465_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068680","article-title":"Multi-scale modeling predicts a balance of tumor necrosis factor-\u03b1 and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection","volume":"8","author":"Cilfone","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2023.121465_bb0195","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/315857","article-title":"Plasma Interleukin-10: tumor necrosis factor (TNF)\u2014\u03b1 ratio is associated with TNF promoter variants and predicts malarial complications","volume":"182","author":"May","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.lfs.2023.121465_bb0200","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/CVI.00019-08","article-title":"Influence of Mycobacterium bovis BCG vaccination on cellular immune response of Guinea pigs challenged with mycobacterium tuberculosis","volume":"15","author":"Ordway","year":"2008","journal-title":"Clin. Vacc. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121465_bb0205","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/stem.2619","article-title":"Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA","volume":"35","author":"Tang","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.lfs.2023.121465_bb0210","article-title":"Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19","author":"Motallebnezhad","year":"2022","journal-title":"Pathol. Res. Pract."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523000991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523000991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:07:11Z","timestamp":1758402431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523000991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":42,"alternative-id":["S0024320523000991"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121465","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of mesenchymal stem cell-derived supernatant nasal administration on lung inflammation and immune response in BCG-vaccinated BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121465"}}